Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
BioPheresis
company
About
BioPheresis Technologies, a biotech company based in Heidelberg, Germany, offers a blood treatment system designed for cancer cure.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $8M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2003
- Number Of Employee
- 1 - 10
- Operating Status
- Active
BioPheresis Technologies is a US Delaware corporation, and its wholly owned operating company, BioPheresis GmbH, incorporated in 2003, is located in Heidelberg, Germany. BioPheresis has developed a new patent protected blood treatment system designed to remove specific cancer-protecting immune-inhibitors from the blood.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$8M
BioPheresis has raised a total of
$8M
in funding over 2 rounds. Their latest funding was raised on
May 13, 2005 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 13, 2005 | Series A | $8M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
BioPheresis is funded by 1 investors.
firstVentury Equity
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
